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Amniocentesis and, recently, chorionic villus sampling Several fetal cell types have been reported to exist
in the maternal circulation. These include fetal tro-(CVS) provide fetal cells for genetic testing and allow
at-risk couples the option of having unaffected off- phoblasts, lymphocytes, granulocytes, nucleated
erythrocytes, and platelets. Except for plateletsspring. The most common indication for prenatal diag-
nosis is advanced maternal age, but a signiﬁcant number (which lack genomic DNA), all of these cell types
have been investigated as a source of fetal cells forof procedures are also performed to identify single-gene
disorders. Unfortunately, with these sampling proce- prenatal diagnosis.
Few investigators have used trophoblast cells as adures comes a small (0.5%–1.0%) procedure-related
risk of miscarriage. Because of this, efforts have been source of fetal cells in maternal circulation. However,
Mueller et al. (1990) reported isolating trophoblastsdirected toward less invasive approaches for prenatal
diagnosis. Currently, the most common strategy for de- from maternal circulation by using murine monoclonal
antibodies (mAb) to human trophoblast antigens.tecting aneuploidy (primarily trisomies 21 and 18) is
midtrimester maternal serum biochemical marker analy- Hawes et al. (1994) identiﬁed a paternal b-globin muta-
tion in a trophoblast preparation enriched from mater-sis, followed by amniocentesis in screen-positive cases.
This approach detects Ç60%–90% of cases of Down nal blood by afﬁnity to a cocktail of mAbs. Durrant et al.
(1996) used a different mAb and were able to correctlysyndrome in pregnant women. Much ongoing research
in this area aims to improve detection efﬁciency by using identify male gender in only 39% of cases. The diagnosis
by FISH analysis of a 47,XYY fetus by enrichment usingnewmarkers, but cases of aneuploidy will still be missed,
and this approach will not be useful for the diagnosis anti-trophoblast antibodies GB25 and GB17 has been
reported (Cacheux et al. 1992). A concern about the useof single-gene disorders. Thus, an ideal strategy would
entail identifying fetal cells in the maternal circulation of trophoblasts for noninvasive prenatal diagnosis is the
fact that these cells are frequently multinucleate, whichand making them available for a range of diagnostic
tests. complicates interphase FISH. In addition, extensive ex-
perience with CVS has demonstrated the presence ofWalknowska et al. (1969) ﬁrst reported the detection
of fetal lymphocytes in the circulation of pregnant conﬁned placental mosaicism (CPM) (Goldberg and
Wohlferd 1997). Thus, cytogenetic results obtainedwomen. After mitogen stimulation, they found rare lym-
phocytes having a small acrocentric chromosome consis- from trophoblast cells might not truly reﬂect the fetal
status.tent with a Y chromosome. These ﬁndings were highly
correlated with women who were carrying a male fetus. Many studies have conﬁrmed the report by Walknow-
ska et al. regarding the presence of fetal lymphocytes inThis report stimulated a wide range of investigations
focusing on the identiﬁcation and enrichment of fetal the maternal circulation. Herzenberg et al. (1979) were
the ﬁrst to attempt to enrich for the population of fetalcells in the maternal circulation and on the analysis of
these cells. lymphocytes. Using ﬂow sorting, they identiﬁed fetal
cells with an antibody against a paternally inherited
HLA antigen, followed by quinacrine staining and Y
chromatin identiﬁcation. Unfortunately, this approach
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Fetal nucleated red blood cells (NRBCs) have been fertilization (Thomas et al. 1994). The cell type is un-
likely to be fetal NRBCs, since fetal vessels are not pres-the most commonly studied cell type, for several reasons.
On the basis of studies of staining for fetal hemoglobin, ent in the villous stroma until Ç8 wk gestation. A more
likely candidate would be circulating trophoblasts. Asit has been known for many years that fetal red blood
cells cross into the maternal circulation (Clayton et al. mentioned above, Hamada et al. (1993) found the con-
centration of fetal cells in nonenriched samples to beõ1/1964), and the frequency of NRBCs in the fetus early
in gestation is relatively high (Thomas and Yoffey 1962). 100,000 in the ﬁrst trimester, but other investigators,
working with enriched samples, found fetal NRBCsThese cells are also fairly well differentiated and likely
to have a limited life span in the maternal circulation. within the ﬁrst trimester (Cheung et al. 1997), suggesting
that a ﬁrst-trimester approach might be feasible.The presence of fetal NRBCs was ﬁrst described by
Bianchi et al. in 1990 (Bianchi et al. 1990). These cells Because of the rarity of fetal cells in maternal circula-
tion, most investigators have utilized a variety of enrich-were identiﬁed by morphologic features, by positive
staining for fetal hemoglobin, and, in females with male ment techniques. There is no clear consensus, at present,
on which techniques produce the best separation asfetuses, by identiﬁcation of Y chromosome–speciﬁc se-
quences. In this study, fetal NRBCs were identiﬁed by judged by the total number of fetal cells recovered and
the ratio of fetal/maternal cells obtained.Most investiga-ﬂow sorting after binding to a mAb to the transferrin
receptor, an antigen expressed on all cells that take up tors begin with Ç20 ml of maternal venous blood from
maternal nonnucleated erythrocytes which are removed,iron, including all NRBCs in maternal blood. Unfortu-
nately, evidence suggests that a signiﬁcant proportion usually by density gradient centrifugation. After this
step, various positive and negative selection techniquesof NRBCs in maternal blood are of maternal origin,
having increased during pregnancy, as compared with have been used after speciﬁc antibody conjugation.
These techniques have included ﬂuorescence-activatednonpregnant controls (Slunga-Talberg et al. 1995).
It is clear that fetal cells in the maternal circulation cell sorting, magnetic activated cell sorting, immuno-
magnetic beads, and antibody-conjugated columns. Re-are few, but the exact frequency is controversial, with
ranges of 1/105–1/109 maternal cells reported. Most of cently several investigators have performed immuno-
staining with fetal hemoglobin antibodies to speciﬁcallythe studies that have attempted to answer this question
have used fetal cell–enrichment techniques and have had identify fetal cells in sorted samples of NRBCs. Zheng
et al. (1993) utilized a mouse anti–fetal hemoglobinan unknown rate of loss because of the enrichment steps.
Hamada et al. (1993) used a direct approach on un- antibody (i.e., UCHg) and FISH analysis to identify fetal
gender from sorted cells. There is some concern withsorted cells. They selected cells that were Y-sequence
positive on FISH analysis and reported that the fre- this approach, because some mothers will have elevated
fetal hemoglobin levels, leading to misidentiﬁcation. Toquency of Y-positive cells increased from õ1/105 in the
ﬁrst trimester to 1/104 at term. The paper by Bianchi et avoid this, Cheung et al. (1996) utilized an anti-embry-
onic (i.e., z) antibody to identify sorted fetal cells.al. (1997) in this issue of the Journal uses quantitative
PCR to determine the number of male fetal-cell DNA The small number of fetal cells obtained has been a
signiﬁcant limitation with this type of analysis. If theequivalents in the blood of pregnant women. They ﬁnd
the mean number of male fetal-cell DNA equivalents small number of cells could be cultured, more material
would be available for analysis. Lo et al. (1994) haveampliﬁed from 16 ml of maternal blood to be 19 (range
0–91), with male DNA detected in 99.3% of pregnant reported the successful culture of fetal erythroid cells,
resulting in a purity rate of 0.001%–0.25%. Valeriowomen carrying a male fetus. There was a sixfold in-
crease in the number of DNA cell equivalents in preg- et al. (1996) used magnetic sorting with biotin-labeled
erythropoietin preenrichment and were able to culturenancies where the fetus had trisomy 21. Equally interest-
ing was the ﬁnding that, in 25.7% of women carrying fetal CFU-E (colony forming unit–erythroid) and M-
BFU-E (mature burst-forming unit–erythroid) cells,a female fetus, male DNA was detected. As pointed out
by the authors, this could reﬂect a vanishing-twin gesta- achieving 18% purity. This approach holds great prom-
ise for providing increased numbers of fetal cells fortion, previous maternal blood transfusion from a male
donor, or persistent cells from a prior male pregnancy. analysis.
Many investigators have reported a number of casesThis ﬁnding emphasizes both the need to use a cell type
with a limited life span and the need for methods to of false-positive results in ﬁnding cells with Y sequences
from blood of women carrying female fetuses. Althoughspeciﬁcally identify cells of fetal origin.
Another important issue is the timing of passage of this may have resulted from nonspeciﬁc ampliﬁcation/
binding or contamination, it has also raised the possibil-fetal cells into the maternal circulation. Investigators
have demonstrated by PCR in mothers carrying male ity, as mentioned above, that cells from past pregnancies
may remain in the maternal circulation. Bianchi et al.fetuses the presence of Y sequences as early as 33 and
40 d of gestation in dated pregnancies following in vitro (1996) reported the presence of male DNA in ﬂow-
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sorted CD34/CD38/ cells from six of eight nonpregnant til a large prospective study is performed, this approach
will not be ready for clinical application. The Nationalwomen who had previously given birth to a son. The
interval from birth to testing was 6 mo–27 years. This Institute of Coronary Heart Disease is currently spon-
soring a phase II clinical trial to evaluate the accuracyﬁnding suggests that there might exist a low-level chime-
rism from past pregnancies. The biological signiﬁcance of cytogenetic diagnosis based on fetal cells in maternal
blood, as compared with traditional amniocentesis orof this is unknown, but Bianchi (1997) has reported an
association between the persistence of fetal cells and CVS (de la Cruz et al. 1995).
Not surprisingly, several important ethical and socialthe later development of autoimmune disorders such as
Sjogren syndrome and scleroderma. issues need to be resolved before widespread or universal
testing of fetal cells in maternal circulation is under-The analysis of fetal cells in maternal circulation has
primarily relied on PCR and FISH techniques. PCR has taken. The ﬁrst issue is whether this type of screening
should be offered to all pregnant women. A comprehen-been used for the ampliﬁcation of sequences in both
nonenriched and enriched maternal blood. Lo et al. sive cost-effectiveness evaluation should be performed
to help answer this question. Related to this is the ques-(1989) showed the ampliﬁcation of Y sequences in non-
enriched maternal blood from women carrying male tion of whether women will feel coerced, by health-care
providers, family, or friends, into being tested. Anpregnancies. They identiﬁed all 12/19 women who later
gave birth to boys. The diagnosis of single-gene disor- equally important issue that has never been resolved
with prenatal diagnosis is the issue of gender selection.ders is also possible if the father carries a mutation or
polymorphism that the mother lacks. For example, both With the availability of an essentially noninvasive ap-
proach to diagnose fetal gender, this technique could bethe detection of fetal hemoglobin Lepore-Boston and the
detection of the Rh D gene have been reported using widely used by families that have a gender preference.
The medical genetics community will need to developthis strategy (Camaschella et al. 1990; Lo et al. 1993).
At present, the accuracy of this approach is unknown. broad-based consensus guidelines in this area.
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